220 related articles for article (PubMed ID: 15571586)
21. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
[TBL] [Abstract][Full Text] [Related]
22. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
[TBL] [Abstract][Full Text] [Related]
23. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
[TBL] [Abstract][Full Text] [Related]
24. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
25. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
[TBL] [Abstract][Full Text] [Related]
26. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?
Lakatos PL; Altorjay I; Mándi Y; Lakatos L; Tumpek J; Kovacs A; Molnar T; Tulassay Z; Miheller P; Palatka K; Szamosi T; Fischer S; Papp J; ; Papp M
Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186
[TBL] [Abstract][Full Text] [Related]
27. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.
Dassopoulos T; Frangakis C; Cruz-Correa M; Talor MV; Burek CL; Datta L; Nouvet F; Bayless TM; Brant SR
Inflamm Bowel Dis; 2007 Feb; 13(2):143-51. PubMed ID: 17206688
[TBL] [Abstract][Full Text] [Related]
29. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
Papp M
Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
[TBL] [Abstract][Full Text] [Related]
30. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
[TBL] [Abstract][Full Text] [Related]
31. Candida albicans colonization and ASCA in familial Crohn's disease.
Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF
Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251
[TBL] [Abstract][Full Text] [Related]
32. Dietary antigens in Crohn's disease: antibodies to porcine pancreatic amylase.
Suzuki H; Fukuda Y; Koizuka H; Tomita T; Hori K; Suzuki M; O'Morain C
Am J Gastroenterol; 2008 Mar; 103(3):656-64. PubMed ID: 18028509
[TBL] [Abstract][Full Text] [Related]
33. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
34. Clinical utility of serological markers in inflammatory bowel disease.
Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
[TBL] [Abstract][Full Text] [Related]
35. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
Standaert-Vitse A; Jouault T; Vandewalle P; Mille C; Seddik M; Sendid B; Mallet JM; Colombel JF; Poulain D
Gastroenterology; 2006 May; 130(6):1764-75. PubMed ID: 16697740
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
[TBL] [Abstract][Full Text] [Related]
37. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease.
Jess T; Riis L; Jespersgaard C; Hougs L; Andersen PS; Orholm MK; Binder V; Munkholm P
Am J Gastroenterol; 2005 Nov; 100(11):2486-92. PubMed ID: 16279904
[TBL] [Abstract][Full Text] [Related]
38. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
[TBL] [Abstract][Full Text] [Related]
39. Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population.
Nagy Z; Karádi O; Rumi G; Rumi G; Pár A; Mózsik G; Czirják L; Süto G
Ann N Y Acad Sci; 2005 Jun; 1051():45-51. PubMed ID: 16126943
[TBL] [Abstract][Full Text] [Related]
40. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.
Esters N; Vermeire S; Joossens S; Noman M; Louis E; Belaiche J; De Vos M; Van Gossum A; Pescatore P; Fiasse R; Pelckmans P; Reynaert H; Poulain D; Bossuyt X; Rutgeerts P;
Am J Gastroenterol; 2002 Jun; 97(6):1458-62. PubMed ID: 12094865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
